Cardiovascular death in rheumatoid arthritis: A population‐based study

Abstract

These results indicate that markers of systemic inflammation confer a statistically significant additional risk for cardiovascular death among patients with RA, even after controlling for traditional cardiovascular risk factors and comorbidities.